DRMA Market Cap History



Below is a table of the DRMA market cap history going back to 11/10/2021:

Date DRMA Market Cap
11/10/202142.31M
3/28/202211.08M
5/13/20227.60M
8/12/20226.67M
11/10/20227.02M
2/17/20233.56M
5/10/20234.16M
8/9/20233.73M
11/9/20232.49M
3/18/20242.52M

Also see: DRMA Shares Outstanding History
and DRMA YTD Return
DRMA Historical Market Cap:
-69.89% CAGR
DRMA Historical Market Cap: +-69.89% CAGR

Mouse over chart for data details
11/10/20213/28/20225/13/20228/12/202211/10/20222/17/20235/10/20238/9/202311/9/20233/18/2024
Dermata Therapeutics is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Co.'s main product candidate, DMT310, is intended to utilize its Spongilla technology for a once weekly treatment of a variety of skin diseases with its initial focus being for the treatment of acne vulgaris. Co.'s second product candidate utilizing its Spongilla technology is its combination treatment, DMT410. DMT410 is intended to consist of one treatment of Co.'s sponge powder followed by one topical application of botulinum toxin for delivery into the dermis. We show 10 historical shares outstanding datapoints in our DRMA shares outstanding history coverage, used to compute DRMA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DRMA market cap history over the course of time is important for investors interested in comparing DRMA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DRMA versus a peer is one thing; comparing DRMA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DRMA can fluctuate over the course of history. With this page we aim to empower investors researching DRMA by allowing them to research the DRMA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree DRMA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Dermata Therapeutics (DRMA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

DRNA Market Cap History
DRRX Market Cap History
DSGN Market Cap History
DTIL Market Cap History
DVA Market Cap History
DVAX Market Cap History
DVCR Market Cap History
DXCM Market Cap History
DYAI Market Cap History
DYN Market Cap History
More Healthcare companies »

 

DRMA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.